NO20034526L - Nye fremgangsmater for fremstilling av oksabispiner - Google Patents

Nye fremgangsmater for fremstilling av oksabispiner

Info

Publication number
NO20034526L
NO20034526L NO20034526A NO20034526A NO20034526L NO 20034526 L NO20034526 L NO 20034526L NO 20034526 A NO20034526 A NO 20034526A NO 20034526 A NO20034526 A NO 20034526A NO 20034526 L NO20034526 L NO 20034526L
Authority
NO
Norway
Prior art keywords
sup
formula
compound
preparation
oxabispins
Prior art date
Application number
NO20034526A
Other languages
English (en)
Other versions
NO20034526D0 (no
Inventor
Lal Cheema
David Clading-Boel
Rhona Sinclair
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of NO20034526D0 publication Critical patent/NO20034526D0/no
Publication of NO20034526L publication Critical patent/NO20034526L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/08—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Steroid Compounds (AREA)
NO20034526A 2001-04-12 2003-10-09 Nye fremgangsmater for fremstilling av oksabispiner NO20034526L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE0101324A SE0101324D0 (sv) 2001-04-12 2001-04-12 New process
PCT/SE2002/000727 WO2002083690A1 (en) 2001-04-12 2002-04-12 New process for the preparation of oxabispidines

Publications (2)

Publication Number Publication Date
NO20034526D0 NO20034526D0 (no) 2003-10-09
NO20034526L true NO20034526L (no) 2003-10-31

Family

ID=20283781

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20034526A NO20034526L (no) 2001-04-12 2003-10-09 Nye fremgangsmater for fremstilling av oksabispiner

Country Status (19)

Country Link
US (2) US7169921B2 (no)
EP (1) EP1385850B1 (no)
JP (1) JP4248880B2 (no)
KR (1) KR100848613B1 (no)
CN (1) CN1267435C (no)
AT (1) ATE284405T1 (no)
AU (1) AU2002249748B2 (no)
BR (1) BR0208861A (no)
CA (1) CA2443475A1 (no)
DE (1) DE60202203T2 (no)
ES (1) ES2233809T3 (no)
IL (2) IL158249A0 (no)
MX (1) MXPA03009211A (no)
NO (1) NO20034526L (no)
NZ (1) NZ528515A (no)
PT (1) PT1385850E (no)
SE (1) SE0101324D0 (no)
WO (1) WO2002083690A1 (no)
ZA (1) ZA200307676B (no)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE0101324D0 (sv) * 2001-04-12 2001-04-12 Astrazeneca Ab New process
GB0223712D0 (en) 2002-10-14 2002-11-20 Astrazeneca Ab Chemical intermediate
US20040192738A1 (en) * 2003-03-18 2004-09-30 Aventis Pharma Deutschland Gmbh 2-(Butyl-1-sulfonylamino)-N-[1(R)-(6-methoxypyridin-3-yl)propyl] benzamide, its use as a medicament, and pharmaceutical preparations comprising it
SE0401539D0 (sv) * 2004-06-15 2004-06-15 Astrazeneca Ab New compounds
SE0401540D0 (sv) * 2004-06-15 2004-06-15 Astrazeneca Ab New compounds
CA2609938A1 (en) 2005-06-13 2006-12-21 Astrazeneca Ab New oxabispidine compounds for the treatment of cardiac arrhythmias
US20090216002A1 (en) * 2005-06-16 2009-08-27 Girindus Ag Synthesis of hydroquinone derivatives
AR057363A1 (es) * 2005-06-20 2007-11-28 Astrazeneca Ab Proceso para la preparacion de oxabispidinas n,n'-disustituidas
EP1896486A4 (en) * 2005-06-20 2010-11-03 Astrazeneca Ab PROCESS FOR THE PREPARATION OF 3,7-DIHYDROXY-1,5-DIAZACYCLOOCTANESE
WO2006137771A1 (en) * 2005-06-20 2006-12-28 Astrazeneca Ab Process for the preparation of sulfonic acid salts of oxabispidines
AR057364A1 (es) * 2005-06-20 2007-11-28 Astrazeneca Ab Proceso para el aislamiento de 4-(oxiranilmetoxi) -benzonitrilos
WO2006137772A1 (en) * 2005-06-20 2006-12-28 Astrazeneca Ab New physical form of n,n´- disubstituted oxabispidines
CA2610205A1 (en) * 2005-06-20 2006-12-28 Astrazeneca Ab Process for the production of (alkoxycarbonylamino)alkyl sulfonates
KR102280614B1 (ko) 2013-03-15 2021-07-21 글로벌 블러드 테라퓨틱스, 인크. 헤모글로빈 조정을 위한 화합물 및 이의 용도
EA201992707A1 (ru) 2013-11-18 2020-06-30 Глобал Блад Терапьютикс, Инк. Соединения и их применения для модуляции гемоглобина

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3196154A (en) 1962-05-17 1965-07-20 Sterling Drug Inc 3-substituted-9-methyl-3, 9-diazabicyclo [3.3.1] nonanes
US5110933A (en) * 1989-11-13 1992-05-05 Board Of Regents Of Oklahoma State University Salts of 3-azabicyclo[3.3.1]nonanes as antiarrhythmic agents, and precursors thereof
SE9704709D0 (sv) * 1997-12-17 1997-12-17 Astra Ab Pharmaceutically active compounds
SE9903759D0 (sv) * 1999-10-18 1999-10-18 Astra Ab Pharmaceutically active compounds
SE0101324D0 (sv) * 2001-04-12 2001-04-12 Astrazeneca Ab New process

Also Published As

Publication number Publication date
CN1267435C (zh) 2006-08-02
ATE284405T1 (de) 2004-12-15
CA2443475A1 (en) 2002-10-24
US20040181060A1 (en) 2004-09-16
JP4248880B2 (ja) 2009-04-02
ES2233809T3 (es) 2005-06-16
NO20034526D0 (no) 2003-10-09
WO2002083690A1 (en) 2002-10-24
JP2004533432A (ja) 2004-11-04
IL158249A0 (en) 2004-05-12
MXPA03009211A (es) 2004-01-29
BR0208861A (pt) 2004-10-19
EP1385850A1 (en) 2004-02-04
US7169921B2 (en) 2007-01-30
KR20030087065A (ko) 2003-11-12
US20070197519A1 (en) 2007-08-23
KR100848613B1 (ko) 2008-07-28
PT1385850E (pt) 2005-03-31
IL158249A (en) 2009-09-01
AU2002249748B2 (en) 2008-02-28
EP1385850B1 (en) 2004-12-08
DE60202203D1 (de) 2005-01-13
DE60202203T2 (de) 2005-12-15
CN1520417A (zh) 2004-08-11
HK1060886A1 (en) 2004-08-27
SE0101324D0 (sv) 2001-04-12
NZ528515A (en) 2005-06-24
ZA200307676B (en) 2004-07-13

Similar Documents

Publication Publication Date Title
NO20034526D0 (no) Nye fremgangsmåter for fremstilling av oksabispiner
DE60037892D1 (de) Nitroimidazolpräparationen zur äusseren anwendung zur behandlung von atopischer dermatitis
DK0623607T3 (da) Benzofuranyl- og -thiophenyl-alkancarboxylsyrederivater
MXPA02011370A (es) Iminoazinas substituidas.
DE602004025344D1 (de) Biologisch abbaubare verzweigte polylactidderivate, die zur bildung von polymermicellen befähigt sind, herstellungsverfahren dafür und verwendung davon
IL159931A0 (en) Process for producing pyridine compound
ATE354622T1 (de) Flüssigkristallines medium
DE50113943D1 (de) 4-alkoxy-cyclohexan-1-amino-carbonsäureester und verfahren zu ihrer herstellung
BR0213814A (pt) Processos para a fabricação de 3-hidroxi-n, 1,6-trialquil-4-oxo-1, 4-diidro piridino-2-carboxamida
DE69420832D1 (de) Die Verwendung von Carbostyrilderivaten zur Herstellung eines Arzneimittels zur Hemmung der Produktion von Interleukin-8
DK0946493T3 (da) Fremgangsmåde til fremstilling af et naphtalenaminderivat
ATE345787T1 (de) Verwendung von cyclohexenon derivaten zur herstellung eines medikaments für die behandlung von dysurie
NO20063989L (no) Fremgangsmater for a produsere 3-O-beskyttede morfinoner og 3-O-beskyttede morfinondienol-karboksylater
BR0009453B1 (pt) processo para a preparação de um composto.
ECSP034920A (es) Proceso para la preparacion de derivados de ciclohexanol
FI956230A0 (fi) beta-aminovinyyliketonit, valmistusmenetelmä sekä niiden käyttö beta-diketonien valmistukseen
AU2001262081A1 (en) Method for producing beta-alaninamides
PT1230211E (pt) Processo para a preparacao de cetiminas
EP1391455A4 (en) PROCESS FOR PREPARING A CHINOLINCARBALDEHYDE
HU9603178D0 (en) Process for producing benzyl-ethers with phase transformation
DE59903779D1 (de) Verfahren zur herstellung von trion-bis(oximether) derivaten sowie damit erhältliche trion-mono- und trion-bis(oximether) derivate
ATE277904T1 (de) Verfahren zur herstellung von ether-verbindungen als insektizide und/oder akarizide und zwischenprodukte dazu
BR0215533A (pt) Processo para a preparação de 3,5,5-trimetil-cicloex-2-eno-1,4-diona
DE60142962D1 (de) Verfahren zur herstellung von pestiziden verbindungen
DE60033542D1 (de) Zusammensetzungen für die elektroporation

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application